Skip to content

Neural reorganization in tinnitus: a high-field functional and antomical MRI study

Neural reorganization in tinnitus: a high-field functional and antomical MRI study - Neural reorganization in tinnitus

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41097
Enrollment
30
Registered
2014-12-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

phantom sound perception tinnitus

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The main inclusion criteria of the patient groups are: * Male or female between 18 and 75 years * Subjective tinnitus (i.e. not caused by an acoustic source inside the head, e.g., vascular abnormalities that cause pulsatile tinnitus) * Stable tinnitus (i.e., present for at least 8 h per day since more than a year) * Tinnitus that is dominant within one of three octaves (low: 3000 Hz; the exact frequency ranges will be determined empirically based on patient availability) * Patient has not received medical care from an otolaryngologist and is able and willing to undergo the MRI measurements, as indicated by written informed consent.;The main inclusion criteria of the healthy subjects are: * Male or female between 18 and 75 years * No tinnitus * Subject is able and willing to undergo the MRI measurements, as indicated by written informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria of the patient groups are: * Fletcher Index > 50 dB HL for both ears (i.e., mean of hearing loss in decibels for 1k, 2k and 4k Hz) * Hyperacusis (oversensitivity to sound), phonophobia (defined as a persistent, abnormal, and unwarranted fear of sound), misophonia (dislike of certain sound), * Neurological-, neurosurgical- and psychiatric history * Use of dopaminergic drugs since this medication greatly influence the fMRI scans (Haslinger et al., 2001, Mattay et al., 2002) * Morbid obesitas (BMI > 35) since it cannot be guaranteed that these subjects will fit in the scanner * Current treatment of tinnitus and implanted devices or other metal objects that are not suitable for MRI. ;Exclusion criteria of the healthy subjects are: * Fletcher Index > 50 dB HL for both ears (i.e. mean of hearing loss in decibels for 1k, 2k and 4k Hz) * Hyperacusis (oversensitivity to sound), phonophobia (defined as a persistent, abnormal, and unwarranted fear of sound), misophonia (dislike of certain sound), * Neurological-, neurosurgical- and psychiatric history * Use of dopaminergic drugs since this medication greatly influence the fMRI scans (Haslinger et al., 2001, Mattay et al., 2002) * Morbid obesitas (BMI > 35) since it cannot be guaranteed that these subjects will fit in the scanner * Current treatment of tinnitus and implanted devices or other metal objects that are not suitable for MRI.

Design outcomes

Primary

MeasureTime frame
The hypothesized link between frequency tuning and tinnitus will be tested by comparing the size and response magnitude of the auditory cortex regions that show tuning to the patient*s specific tinnitus frequency vs. regions that show tuning to the other (non-tinnitus) frequencies. In this way, patients can serve as their own controls, in addition to matching healthy controls. Furthermore, anatomical features (measures of myelin content and cortical thickness) will be assessed in the same regions of interest.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)